Partillion Bioscience Corporation Announces Seed Financing, Expanded Board, And New Partnership With Alloy Therapeutics
Sep 26, 2023•almost 2 years ago
Round Type
seed
Investors
Alloy TherapeuticsPaladin CapitalVertical Venture PartnersNd CapitalGeneral InceptionInitiate StudiosAlloy Therapeutics, Inc.
Description
Partillion Bioscience Corporation ("Partillion"), a life science tools company, today announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear agreement with Alloy Therapeutics, Inc. as a Preferred Partner providing antibody discovery services using Partillion's Nanovial technology. Nanovials solve numerous industry challenges as the first microscale test tubes engineered for the isolation and analysis of individual cells that are compatible with standard laboratory equipment. The investment follows the earlier incubation support from venture studio partners Initiate Studios and General Inception
FundzWatch™ Score
62
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers